These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 10428205

  • 1. Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207).
    Carew JF, Kooby DA, Halterman MW, Federoff HJ, Fong Y.
    Hum Gene Ther; 1999 Jul 01; 10(10):1599-606. PubMed ID: 10428205
    [Abstract] [Full Text] [Related]

  • 2. Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.
    Chahlavi A, Todo T, Martuza RL, Rabkin SD.
    Neoplasia; 1999 Jun 01; 1(2):162-9. PubMed ID: 10933051
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).
    Kooby DA, Carew JF, Halterman MW, Mack JE, Bertino JR, Blumgart LH, Federoff HJ, Fong Y.
    FASEB J; 1999 Aug 01; 13(11):1325-34. PubMed ID: 10428757
    [Abstract] [Full Text] [Related]

  • 5. Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy.
    Coukos G, Makrigiannakis A, Montas S, Kaiser LR, Toyozumi T, Benjamin I, Albelda SM, Rubin SC, Molnar-Kimber KL.
    Cancer Gene Ther; 2000 Feb 01; 7(2):275-83. PubMed ID: 10770637
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters.
    Nakano K, Todo T, Chijiiwa K, Tanaka M.
    Mol Ther; 2001 Apr 01; 3(4):431-7. PubMed ID: 11319903
    [Abstract] [Full Text] [Related]

  • 7. Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.
    Toda M, Rabkin SD, Martuza RL.
    Hum Gene Ther; 1998 Oct 10; 9(15):2177-85. PubMed ID: 9794202
    [Abstract] [Full Text] [Related]

  • 8. G207, modified herpes simplex virus type 1, kills human pancreatic cancer cells in vitro.
    Lee JH, Federoff HJ, Schoeniger LO.
    J Gastrointest Surg; 1999 Oct 10; 3(2):127-31; discussion 132-3. PubMed ID: 10457334
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors.
    Todo T, Rabkin SD, Martuza RL.
    Cancer Gene Ther; 2000 Jun 10; 7(6):939-46. PubMed ID: 10880026
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oncolytic herpes simplex virus type-1 therapy in a highly infiltrative animal model of human glioblastoma.
    Huszthy PC, Goplen D, Thorsen F, Immervoll H, Wang J, Gutermann A, Miletic H, Bjerkvig R.
    Clin Cancer Res; 2008 Mar 01; 14(5):1571-80. PubMed ID: 18316582
    [Abstract] [Full Text] [Related]

  • 14. Replication-selective herpes simplex virus type 1 mutant therapy of cervical cancer is enhanced by low-dose radiation.
    Blank SV, Rubin SC, Coukos G, Amin KM, Albelda SM, Molnar-Kimber KL.
    Hum Gene Ther; 2002 Mar 20; 13(5):627-39. PubMed ID: 11916486
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficient gene transfer to human squamous cell carcinomas by the herpes simplex virus type 1 amplicon vector.
    Carew JF, Federoff H, Halterman M, Kraus DH, Savage H, Sacks PG, Schantz SP, Shah JP, Fong Y.
    Am J Surg; 1998 Nov 20; 176(5):404-8. PubMed ID: 9874422
    [Abstract] [Full Text] [Related]

  • 17. Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1.
    Yazaki T, Manz HJ, Rabkin SD, Martuza RL.
    Cancer Res; 1995 Nov 01; 55(21):4752-6. PubMed ID: 7585498
    [Abstract] [Full Text] [Related]

  • 18. Multimutated herpes simplex virus g207 is a potent inhibitor of angiogenesis.
    Cinatl J, Michaelis M, Driever PH, Cinatl J, Hrabeta J, Suhan T, Doerr HW, Vogel JU.
    Neoplasia; 2004 Nov 01; 6(6):725-35. PubMed ID: 15720798
    [Abstract] [Full Text] [Related]

  • 19. Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses.
    McAuliffe PF, Jarnagin WR, Johnson P, Delman KA, Federoff H, Fong Y.
    J Gastrointest Surg; 2000 Nov 01; 4(6):580-8. PubMed ID: 11307092
    [Abstract] [Full Text] [Related]

  • 20. Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy.
    Todo T, Rabkin SD, Chahlavi A, Martuza RL.
    Hum Gene Ther; 1999 Nov 20; 10(17):2869-78. PubMed ID: 10584932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.